부문: 보건의료 업종: 의약품 제조업체 - 일반 주식 시장 - 시세 및 가격
가격, 시가 총액, PE 및 EPS가 포함된 모든 주식 목록
모든 나라들
모든 거래소
- {{item.name}}
- 모든 거래소
- BSE (10)
- Budapest (1)
- Buenos Aires (12)
- Canadian Sec (1)
- Cboe CA (1)
- Frankfurt (39)
- Helsinki (2)
- HKSE (1)
- IOB (15)
- Istanbul (1)
- KSE (3)
- Mexico (14)
- Milan (1)
- Munich (1)
- NSE (8)
- NYSE (6)
- OTC Markets OTCPK (28)
- OTC Markets OTCQX (4)
- Paris (2)
- Santiago (4)
- São Paulo (13)
- SES (1)
- Shanghai (3)
- Shenzhen (4)
- Stockholm (1)
- Swiss (5)
- Taipei Exchange (1)
- Tech Market Large (4)
- Tech Market Small (1)
- Tokyo (7)
- Vienna (13)
- XETRA (11)
보건의료 (218)
- {{item.name}}
- 모든 업종
- 보건의료 (218)
의약품 제조업체 - 일반 (218)
| 이름 이름 | 가격 가격 |
24h% 7d chart 24h% & 7d |
시가 총액 시가 총액 | 거래량 거래량 | 24h 최저가 | 24h 최고가 | 시가 총액 | 주가수익비율 | 주당순이익 | 예측 |
|---|
| 이름 이름 | 가격 가격 |
24h% 7d chart 24h% & 7d |
시가 총액 시가 총액 | 거래량 거래량 | 24h 최저가 | 24h 최고가 | 시가 총액 | 주가수익비율 | 주당순이익 | 예측 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.marketcap }} {{ item.marketcap_usd }} | {{ item.pe }} | {{ item.eps }} {{ item.eps_usd }} |
|
|
| Eli Lilly and Company LLY | $1,059.70 — |
+1.57
|
$949.98B — | $4.14M — | $1,038.00 — | $1,066.65 — | $949.98B — | 51.81 | $20.45 — | ||
| AbbVie Inc. 0QCV.IL | $234.00 — |
+1.52
|
$420.96B — | $1.95K — | $229.45 — | $237.97 — | $420.96B — | 48.14 | $4.86 — | ||
| AbbVie ABBV | $236.28 — |
+2.98
|
$417.60B — | $7.98M — | $230.14 — | $238.00 — | $417.60B — | 177.65 | $1.33 — | ||
| Roche Holding AG RHHVF | $390.00 — |
+1.56
|
$311.95B — | $63.00 — | $384.16 — | $390.00 — | $311.95B — | 26.58 | $14.67 — | ||
| Roche Holding AG 0QOK.IL | CHF 312.30 355.33 USD |
+0.63
|
CHF 265.01B 301.52B USD | CHF 415.44K 472.68K USD | CHF 311.90 354.88 USD | CHF 315.80 359.31 USD | CHF 265.01B 301.52B USD | 24.02 | CHF 13.00 14.79 USD | ||
| Roche Holding AG RO.SW | CHF 326.20 371.15 USD |
+1.05
|
CHF 259.76B 295.55B USD | CHF 22.56K 25.67K USD | CHF 323.40 367.96 USD | CHF 327.40 372.51 USD | CHF 259.76B 295.55B USD | 27.76 | CHF 11.75 13.37 USD | ||
| Roche Holding AG ROG.SW | CHF 315.60 359.09 USD |
+1.22
|
CHF 253.19B 288.08B USD | CHF 1.62M 1.84M USD | CHF 311.90 354.88 USD | CHF 315.90 359.43 USD | CHF 253.19B 288.08B USD | 26.85 | CHF 11.75 13.37 USD | ||
| AstraZeneca AZN | $91.00 — |
+2.62
|
$282.15B — | $7.40M — | $89.41 — | $91.91 — | $282.15B — | 30.23 | $3.01 — | ||
| AstraZeneca PLC ZEG.DE | €157.40 172.06 USD |
+1.48
|
€244.01B 266.74B USD | €8.12K 8.88K USD | €153.90 168.23 USD | €157.40 172.06 USD | €244.01B 266.74B USD | 30.21 | €5.21 5.7 USD | ||
| AstraZeneca PLC AZN.ST | SEK 1,732.00 169.06 USD |
+1.52
|
SEK 2.69T 262.1B USD | SEK 290.04K 28.31K USD | SEK 1,688.50 164.82 USD | SEK 1,733.50 169.21 USD | SEK 2.69T 262.1B USD | 30.12 | SEK 57.49 5.61 USD | ||
| Merck & MRK | $97.76 — |
+2.94
|
$244.18B — | $23.15M — | $95.36 — | $100.27 — | $244.18B — | 12.93 | $7.56 — | ||
| Novartis AG NVSEF | $123.69 — |
0
|
$243.33B — | $10.00 — | $137.10 — | $137.10 — | $243.33B — | 16.92 | $7.31 — | ||
| Novartis AG NOVN.SW | CHF 102.88 117.06 USD |
+2.45
|
CHF 199.16B 226.6B USD | CHF 3.54M 4.03M USD | CHF 99.45 113.15 USD | CHF 102.98 117.17 USD | CHF 199.16B 226.6B USD | 17.58 | CHF 5.85 6.66 USD | ||
| Merck & Co., Inc. 0QAH.IL | $77.14 — |
+0.05
|
$195.74B — | $0.00 — | $0.00 — | $0.00 — | $195.74B — | 63.22 | $1.22 — | ||
| Amgen AMGN | $337.54 — |
+1.15
|
$181.76B — | $4.08M — | $334.74 — | $342.84 — | $181.76B — | 26.08 | $12.94 — | ||
| Gilead Sciences, Inc. 0QYQ.IL | $125.60 — |
-1.64
|
$156.50B — | $3.94K — | $124.33 — | $127.73 — | $156.50B — | 28.87 | $4.35 — | ||
| Pfizer Inc. PFE.NE | CA$11.34 8.41 USD |
+2.25
|
CA$197.22B 146.35B USD | CA$197.62K 146.64K USD | CA$11.14 8.27 USD | CA$11.57 8.59 USD | CA$197.22B 146.35B USD | 13.82 | CA$0.82 0.61 USD | ||
| Pfizer Inc. 0Q1N.IL | $23.59 — |
+0.17
|
$142.98B — | $300.00 — | $0.00 — | $0.00 — | $142.98B — | 6.27 | $3.76 — | ||
| Pfizer Inc. PFE.DE | €21.96 24 USD |
+2.83
|
€124.83B 136.46B USD | €59.53K 65.08K USD | €21.17 23.14 USD | €21.99 24.04 USD | €124.83B 136.46B USD | 14.73 | €1.49 1.63 USD | ||
| Sanofi 0A2V.IL | $49.45 — |
0
|
$131.22B — | $35.00 — | $0.00 — | $0.00 — | $131.22B — | 13.73 | $3.60 — | ||
| Sanofi 0O59.IL | €86.15 94.17 USD |
+0.78
|
€113.63B 124.21B USD | €1.58M 1.73M USD | €84.90 92.81 USD | €86.50 94.56 USD | €113.63B 124.21B USD | 12.57 | €6.85 7.49 USD | ||
| Sanofi SNYNF | $98.30 — |
-0.49
|
$120.83B — | $820.00 — | $103.00 — | $103.00 — | $120.83B — | 16.19 | $6.07 — | ||
| Sanofi SNW.DE | €86.25 94.28 USD |
+0.87
|
€104.92B 114.69B USD | €6.33K 6.92K USD | €85.49 93.45 USD | €86.46 94.51 USD | €104.92B 114.69B USD | 16.45 | €5.24 5.73 USD | ||
| Bristol-Myers Squibb Company 0R1F.IL | $45.83 — |
+0.11
|
$98.52B — | $6.08K — | $45.68 — | $46.95 — | $98.52B — | 12.35 | $3.71 — | ||
| GSK plc GSK | $47.19 — |
+2.34
|
$95.31B — | $3.99M — | $46.47 — | $47.31 — | $95.31B — | 13.59 | $3.47 — | ||
| Bristol-Myers Squibb Company BMY | $46.25 — |
+0.67
|
$94.15B — | $14.09M — | $45.52 — | $46.99 — | $94.15B — | 15.57 | $2.97 — | ||
| Chugai Pharmaceutical Co., Ltd. CHGCY | $26.87 — |
+3.83
|
$89.36B — | $62.84K — | $26.64 — | $26.95 — | $89.36B — | 34.89 | $0.77 — | ||
| Daiichi Sankyo Company, Limited 4568.T | ¥3,700 24.98 USD |
+2.01
|
¥7T 46.23B USD | ¥15M 103.83K USD | ¥3,562 24.04 USD | ¥3,700 24.98 USD | ¥7T 46.23B USD | 24.75 | ¥149 1.01 USD | ||
| Daiichi Sankyo Company DSKYF | $23.47 — |
+4.68
|
$44.10B — | $500.00 — | $22.00 — | $22.00 — | $44.10B — | 24.44 | $0.96 — | ||
| Daiichi Sankyo Company, Limited DSNKY | $23.66 — |
+4.09
|
$43.95B — | $31.11K — | $22.90 — | $23.68 — | $43.95B — | 24.64 | $0.96 — | ||
| Bayer Aktiengesellschaft BAYRY | $7.91 — |
+3.13
|
$32.07B — | $58.76K — | $7.86 — | $7.96 — | $32.07B — | 0 | -$0.06 — | ||
| Otsuka Holdings Co., Ltd. 4578.T | ¥8,567 57.83 USD |
+2.82
|
¥5T 30.54B USD | ¥2M 11.7K USD | ¥8,316 56.14 USD | ¥8,576 57.89 USD | ¥5T 30.54B USD | 11.24 | ¥762 5.14 USD | ||
| Otsuka Holdings Co., Ltd. OTSKY | $27.62 — |
+5.66
|
$30.12B — | $7.67K — | $27.13 — | $27.62 — | $30.12B — | 11.27 | $2.45 — | ||
| Bayer Aktiengesellschaft BAYN.F | €27.75 30.33 USD |
+3.01
|
€27.26B 29.8B USD | €1.93K 2.11K USD | €26.72 29.21 USD | €27.75 30.33 USD | €27.26B 29.8B USD | 0 | -€0.20 -0.2 USD | ||
| Bayer Aktiengesellschaft BAYN.DE | €27.59 30.15 USD |
+2.22
|
€27.10B 29.62B USD | €2.83M 3.09M USD | €26.64 29.12 USD | €27.89 30.49 USD | €27.10B 29.62B USD | 0 | -€0.20 -0.2 USD | ||
| Biogen BIIB | $175.30 — |
+4.23
|
$25.72B — | $2.27M — | $167.71 — | $176.01 — | $25.72B — | 15.97 | $10.97 — | ||
| Astellas Pharma Inc. 4503.T | ¥1,964 13.26 USD |
-0.76
|
¥4T 23.75B USD | ¥17M 116.14K USD | ¥1,945 13.13 USD | ¥1,979 13.36 USD | ¥4T 23.75B USD | 28.24 | ¥70 0.47 USD | ||
| Astellas Pharma Inc. ALPMY | $12.62 — |
+1.2
|
$22.68B — | $4.60K — | $12.52 — | $12.64 — | $22.68B — | 28.04 | $0.45 — | ||
| CSPC Pharmaceutical CHJTF | $0.95 — |
0
|
$11.73B — | $1.76K — | $1.10 — | $1.10 — | $11.73B — | 19.00 | $0.05 — | ||
| Recordati Industria Chimica e Farmaceutica S.p.A. 0KBS.IL | €50.72 55.44 USD |
+0.33
|
€10.54B 11.52B USD | €10.50K 11.47K USD | €50.25 54.93 USD | €51.10 55.86 USD | €10.54B 11.52B USD | 27.26 | €1.86 2.03 USD | ||
| Recordati Industria Chimica e Farmaceutica S.p.A. REC.MI | €50.75 55.48 USD |
+0.59
|
€10.38B 11.35B USD | €249.04K 272.23K USD | €50.25 54.93 USD | €51.10 55.86 USD | €10.38B 11.35B USD | 26.29 | €1.93 2.11 USD | ||
| CSPC Pharmaceutical CSPCY | $3.79 — |
-3.56
|
$10.95B — | $1.25K — | $3.70 — | $3.79 — | $10.95B — | 19.94 | $0.19 — | ||
| CSPC Pharmaceutical Group Limited CVGU.F | €3.22 3.52 USD |
+1.9
|
€9.66B 10.56B USD | €200.00K 218.63K USD | €3.22 3.52 USD | €3.22 3.52 USD | €9.66B 10.56B USD | 20.12 | €0.16 0.17 USD | ||
| Orion Oyj ORNAV.HE | €59.90 65.48 USD |
+0.17
|
€8.46B 9.25B USD | €5.07K 5.54K USD | €58.90 64.39 USD | €59.90 65.48 USD | €8.46B 9.25B USD | 26.86 | €2.23 2.44 USD | ||
| Orion Oyj ORNBV.HE | €59.95 65.53 USD |
+0.25
|
€8.43B 9.22B USD | €180.16K 196.94K USD | €58.90 64.39 USD | €59.95 65.53 USD | €8.43B 9.22B USD | 26.88 | €2.23 2.44 USD | ||
| Orion Oyj 0M2O.IL | €59.58 65.12 USD |
-0.96
|
€8.40B 9.18B USD | €18.42K 20.13K USD | €58.80 64.28 USD | €59.95 65.53 USD | €8.40B 9.18B USD | 27.32 | €2.18 2.38 USD | ||
| Kyowa Kirin Co., Ltd. 4151.T | ¥2,568 17.33 USD |
+3.74
|
¥1T 9.07B USD | ¥3M 19.6K USD | ¥2,494 16.84 USD | ¥2,570 17.34 USD | ¥1T 9.07B USD | 34.96 | ¥73 0.5 USD | ||
| Grifols, S.A. 0RDU.IL | €10.18 11.12 USD |
-0.17
|
€7.23B 7.91B USD | €252.95K 276.51K USD | €9.93 10.86 USD | €10.21 11.16 USD | €7.23B 7.91B USD | 63.59 | €0.16 0.17 USD | ||
| Grifols, S.A. 0RDV.IL | €7.27 7.95 USD |
-2.02
|
€7.16B 7.83B USD | €698.00 763.01 USD | €7.29 7.97 USD | €7.29 7.97 USD | €7.16B 7.83B USD | 45.45 | €0.16 0.17 USD | ||
| Grifols, S.A. GRFS | $8.40 — |
-0.36
|
$6.93B — | $280.17K — | $8.34 — | $8.45 — | $6.93B — | 13.33 | $0.63 — | ||
| Ono Pharmaceutical Co., Ltd. 4528.T | ¥2,078 14.02 USD |
+0.95
|
¥976B 6.59B USD | ¥3M 20.96K USD | ¥2,041 13.78 USD | ¥2,096 14.15 USD | ¥976B 6.59B USD | 18.55 | ¥112 0.76 USD | ||
| Ono Pharmaceutical OPHLY | $4.38 — |
+2.58
|
$6.23B — | $8.60K — | $4.38 — | $4.41 — | $6.23B — | 18.25 | $0.24 — | ||
| Santen Pharmaceutical SNPHY | $10.68 — |
+4.91
|
$3.51B — | $124.00 — | $10.68 — | $10.68 — | $3.51B — | 17.80 | $0.60 — | ||
| Santen Pharmaceutical Co., Ltd. 4536.T | ¥1,612 10.88 USD |
+1.99
|
¥519B 3.5B USD | ¥998K 6.74K USD | ¥1,584 10.69 USD | ¥1,612 10.88 USD | ¥519B 3.5B USD | 17.39 | ¥93 0.63 USD | ||
| Organon & Co. 0A9W.IL | $9.27 — |
0
|
$2.57B — | $1.00 — | $0.00 — | $0.00 — | $2.57B — | 3.14 | $2.95 — | ||
| Haw Par Corporation Limited H02.SI | SGD 15.21 11.4 USD |
-1.23
|
SGD 3.37B 2.52B USD | SGD 116.60K 87.39K USD | SGD 15.12 11.33 USD | SGD 15.35 11.5 USD | SGD 3.37B 2.52B USD | 13.46 | SGD 1.13 0.85 USD | ||
| EIS Eczacibasi Ilaç, Sinai ve Finansal Yatirimlar Sanayi ve Ticaret A.S. ECILC.IS | TRY 105.10 3.3 USD |
+1.06
|
TRY 72.02B 2.26B USD | TRY 7.98M 250.63K USD | TRY 103.20 3.24 USD | TRY 106.60 3.35 USD | TRY 72.02B 2.26B USD | 30.46 | TRY 3.45 0.11 USD | ||
| Zhejiang Wolwo Bio-Pharmaceutical Co., Ltd. 300357.SZ | CN¥30.00 4.17 USD |
-5
|
CN¥15.71B 2.18B USD | CN¥7.05M 980.89K USD | CN¥29.93 4.16 USD | CN¥31.86 4.43 USD | CN¥15.71B 2.18B USD | 40.00 | CN¥0.75 0.1 USD | ||
| Organon & OGN | $7.20 — |
+0.98
|
$1.87B — | $5.62M — | $7.14 — | $7.44 — | $1.87B — | 3.76 | $1.91 — | ||
| GuangYuYuan Chinese Herbal Medicine Co., Ltd. 600771.SS | CN¥19.41 2.7 USD |
-0.36
|
CN¥9.50B 1.32B USD | CN¥9.93M 1.38M USD | CN¥19.26 2.68 USD | CN¥19.74 2.74 USD | CN¥9.50B 1.32B USD | 114.17 | CN¥0.17 0.02 USD | ||
| Cosmo Pharmaceuticals N.V. COPN.SW | CHF 67.10 76.35 USD |
-0.45
|
CHF 1.07B 1.22B USD | CHF 20.57K 23.41K USD | CHF 65.20 74.18 USD | CHF 67.10 76.35 USD | CHF 1.07B 1.22B USD | 20.27 | CHF 3.31 3.77 USD | ||
| Marksans Pharma Limited MARKSANS.NS | ₹191.73 2.32 USD |
-0.69
|
₹86.89B 1.05B USD | ₹683.32K 8.27K USD | ₹189.21 2.29 USD | ₹193.18 2.34 USD | ₹86.89B 1.05B USD | 24.70 | ₹7.76 0.09 USD | ||
| Zhejiang Int'l Group Co.,Ltd. 000411.SZ | CN¥11.07 1.54 USD |
-3.82
|
CN¥5.78B 803.3M USD | CN¥5.14M 715K USD | CN¥11.05 1.54 USD | CN¥11.52 1.6 USD | CN¥5.78B 803.3M USD | 12.30 | CN¥0.90 0.13 USD | ||
| TONG REN TANG 1666.HK | HK$4.67 0.6 USD |
-0.85
|
HK$5.98B 764.78M USD | HK$625.00K 79.91K USD | HK$4.65 0.59 USD | HK$4.70 0.6 USD | HK$5.98B 764.78M USD | 12.62 | HK$0.37 0.05 USD | ||
| Hangzhou Bio-Sincerity Pharma-Tech Co.,Ltd. 301096.SZ | CN¥48.80 6.79 USD |
-4.33
|
CN¥5.33B 741.15M USD | CN¥2.74M 381.14K USD | CN¥48.80 6.79 USD | CN¥51.23 7.12 USD | CN¥5.33B 741.15M USD | 0 | -CN¥1.74 -0.2 USD | ||
| Shanghai Shenqi Pharmaceutical Investment Management Co., Ltd. 900904.SS | $0.51 — |
-1.74
|
$470.83M — | $263.50K — | $0.50 — | $0.51 — | $470.83M — | 25.40 | $0.02 — | ||
| Hubei Guangji Pharmaceutical Co., Ltd. 000952.SZ | CN¥7.12 0.99 USD |
-5.19
|
CN¥2.47B 343.28M USD | CN¥12.46M 1.73M USD | CN¥7.08 0.98 USD | CN¥7.58 1.05 USD | CN¥2.47B 343.28M USD | 0 | -CN¥0.67 -0.09 USD | ||
| Amarin AMRN | $16.38 — |
-0.3
|
$340.58M — | $63.73K — | $16.05 — | $16.71 — | $340.58M — | 0 | -$4.20 — | ||
| SMS Pharmaceuticals Limited SMSPHARMA.NS | ₹281.90 3.41 USD |
-0.7
|
₹26.43B 319.8M USD | ₹134.19K 1.62K USD | ₹278.50 3.37 USD | ₹286.00 3.46 USD | ₹26.43B 319.8M USD | 29.12 | ₹9.68 0.12 USD | ||
| Hangzhou TianMuShan Pharmaceutical Enterprise Co.,Ltd 600671.SS | CN¥16.61 2.31 USD |
-4.92
|
CN¥2.02B 281.25M USD | CN¥2.89M 402.45K USD | CN¥16.59 2.31 USD | CN¥17.65 2.45 USD | CN¥2.02B 281.25M USD | 61.51 | CN¥0.27 0.04 USD | ||
| Dimed S.A. Distribuidora de Medicamentos PNVL3.SA | R$9.21 1.87 USD |
-0.43
|
R$1.37B 278.62M USD | R$328.70K 66.62K USD | R$9.10 1.84 USD | R$9.25 1.87 USD | R$1.37B 278.62M USD | 12.27 | R$0.75 0.15 USD | ||
| Eli Lilly and Company LLY.MX | MX$19,636.00 1162.69 USD |
+2.41
|
MX$17.69T 1.05T USD | MX$215.00 12.73 USD | MX$19,250.00 1139.84 USD | MX$19,650.00 1163.52 USD | MX$17.69T 1.05T USD | 52.52 | MX$373.87 22.14 USD | ||
| Eli Lilly and Company LILY34.SA | R$190.37 38.58 USD |
+1.97
|
R$5.15T 1.04T USD | R$37.84K 7.67K USD | R$185.02 37.5 USD | R$192.17 38.95 USD | R$5.15T 1.04T USD | 52.58 | R$3.62 0.73 USD | ||
| Eli Lilly and Company LLY.F | €920.90 1006.67 USD |
+2.34
|
€832.51B 910.04B USD | €939.00 1.03K USD | €900.80 984.7 USD | €924.50 1010.6 USD | €832.51B 910.04B USD | 51.94 | €17.73 19.38 USD | ||
| Eli Lilly and Company LLYC.VI | €914.60 999.78 USD |
+0.27
|
€826.11B 903.05B USD | €100.00 109.31 USD | €901.30 985.24 USD | €915.60 1000.87 USD | €826.11B 903.05B USD | 51.96 | €17.60 19.24 USD | ||
| Eli Lilly and Company LLY.DE | €914.20 999.34 USD |
+0.24
|
€825.39B 902.27B USD | €3.19K 3.49K USD | €900.30 984.15 USD | €920.90 1006.67 USD | €825.39B 902.27B USD | 51.67 | €17.69 19.34 USD | ||
| Eli Lilly and Company LLY.SW | CHF 830.00 944.36 USD |
+3.11
|
CHF 747.43B 850.42B USD | CHF 10.00 11.38 USD | CHF 830.00 944.36 USD | CHF 830.00 944.36 USD | CHF 747.43B 850.42B USD | 50.64 | CHF 16.39 18.65 USD | ||
| Johnson & Johnson JNJ.BA | ARS 20,600.00 24.35 USD |
+2.08
|
ARS 678.40T 801.9B USD | ARS 12.64K 14.94 USD | ARS 20,150.00 23.82 USD | ARS 20,810.00 24.6 USD | ARS 678.40T 801.9B USD | 7.07 | ARS 2.91K 3.44 USD | ||
| AbbVie Inc. ABBV.BA | ARS 35,620.00 42.1 USD |
+4.21
|
ARS 641.14T 757.85B USD | ARS 708.00 0.84 USD | ARS 34,080.00 40.28 USD | ARS 35,900.00 42.43 USD | ARS 641.14T 757.85B USD | 19.19 | ARS 1.86K 2.19 USD | ||
| Johnson & Johnson JNJB34.SA | R$73.47 14.89 USD |
+1.91
|
R$2.68T 544.02B USD | R$12.35K 2.5K USD | R$72.09 14.61 USD | R$74.56 15.11 USD | R$2.68T 544.02B USD | 19.96 | R$3.68 0.75 USD | ||
| Johnson & Johnson JNJ.MX | MX$3,780.00 223.82 USD |
+0.91
|
MX$9.14T 541.33B USD | MX$1.97K 116.59 USD | MX$3,750.01 222.05 USD | MX$3,800.30 225.02 USD | MX$9.14T 541.33B USD | 19.90 | MX$189.92 11.25 USD | ||
| AstraZeneca PLC AZN.BA | ARS 69,025.00 81.59 USD |
+4.27
|
ARS 408.31T 482.64B USD | ARS 152.00 0.18 USD | ARS 66,575.00 78.69 USD | ARS 69,150.00 81.74 USD | ARS 408.31T 482.64B USD | 8.15 | ARS 8.47K 10.01 USD | ||
| Johnson & Johnson JNJ.VI | €179.14 195.82 USD |
+1.77
|
€431.60B 471.8B USD | €57.00 62.31 USD | €176.06 192.46 USD | €179.14 195.82 USD | €431.60B 471.8B USD | 20.03 | €8.94 9.77 USD | ||
| Johnson & Johnson JNJ.DE | €178.88 195.54 USD |
+1.5
|
€430.97B 471.11B USD | €4.39K 4.8K USD | €176.02 192.41 USD | €179.50 196.22 USD | €430.97B 471.11B USD | 19.94 | €8.97 9.81 USD | ||
| Johnson & Johnson JNJ.F | €178.18 194.77 USD |
+1.4
|
€429.29B 469.27B USD | €765.00 836.25 USD | €175.02 191.32 USD | €178.60 195.23 USD | €429.29B 469.27B USD | 19.88 | €8.96 9.79 USD | ||
| Johnson & Johnson JNJ.SN | $191.05 — |
0
|
$465.34B — | $0.00 — | $191.05 — | $191.05 — | $465.34B — | 18.45 | $10.35 — | ||
| AbbVie Inc. ABBV.MX | MX$4,380.00 259.35 USD |
+3.47
|
MX$7.77T 459.84B USD | MX$410.00 24.28 USD | MX$4,279.91 253.42 USD | MX$4,384.56 259.62 USD | MX$7.77T 459.84B USD | 181.51 | MX$24.13 1.43 USD | ||
| AbbVie Inc. ABBV34.SA | R$79.78 16.17 USD |
+3.76
|
R$2.27T 459.66B USD | R$7.32K 1.48K USD | R$76.89 15.58 USD | R$80.31 16.28 USD | R$2.27T 459.66B USD | 181.31 | R$0.44 0.09 USD | ||
| Merck & Co., Inc. MRK.BA | ARS 29,700.00 35.11 USD |
+5.32
|
ARS 354.23T 418.71B USD | ARS 2.13K 2.52 USD | ARS 28,260.00 33.4 USD | ARS 30,220.00 35.72 USD | ARS 354.23T 418.71B USD | 0.27 | ARS 106.37K 125.73 USD | ||
| AbbVie Inc. 4AB.F | €205.50 224.64 USD |
+3.47
|
€363.88B 397.77B USD | €123.00 134.46 USD | €198.00 216.44 USD | €205.50 224.64 USD | €363.88B 397.77B USD | 178.69 | €1.15 1.26 USD | ||
| AbbVie Inc. ABBV.VI | €202.00 220.81 USD |
+1.3
|
€357.01B 390.26B USD | €0.00 0 USD | €199.40 217.97 USD | €202.00 220.81 USD | €357.01B 390.26B USD | 177.19 | €1.14 1.25 USD | ||
| Novartis AG NVS.BA | ARS 48,040.00 56.78 USD |
+3.49
|
ARS 322.67T 381.41B USD | ARS 181.00 0.21 USD | ARS 47,940.00 56.67 USD | ARS 48,220.00 57 USD | ARS 322.67T 381.41B USD | 2.33 | ARS 20.57K 24.31 USD | ||
| Roche Holding AG ROGN.MX | MX$6,750.00 399.68 USD |
0
|
MX$5.38T 318.27B USD | MX$90.00 5.33 USD | MX$6,750.00 399.68 USD | MX$6,750.00 399.68 USD | MX$5.38T 318.27B USD | 25.25 | MX$267.30 15.83 USD | ||
| Roche Holding AG RHHBF | $396.06 — |
-1.6
|
$315.39B — | $18.00 — | $377.75 — | $377.75 — | $315.39B — | 27.03 | $14.65 — | ||
| Amgen Inc. AMGN.BA | ARS 17,070.00 20.18 USD |
+2.71
|
ARS 265.30T 313.59B USD | ARS 472.00 0.56 USD | ARS 16,630.00 19.66 USD | ARS 17,210.00 20.34 USD | ARS 265.30T 313.59B USD | 0.18 | ARS 90.96K 107.52 USD | ||
| AstraZeneca PLC A1ZN34.SA | R$82.50 16.72 USD |
+3.96
|
R$1.53T 311.07B USD | R$6.16K 1.25K USD | R$80.08 16.23 USD | R$82.50 16.72 USD | R$1.53T 311.07B USD | 30.89 | R$2.67 0.54 USD | ||
| AstraZeneca PLC AZNN.MX | MX$1,680.00 99.48 USD |
+2.75
|
MX$5.25T 310.76B USD | MX$10.00 0.59 USD | MX$1,680.00 99.48 USD | MX$1,680.00 99.48 USD | MX$5.25T 310.76B USD | 30.40 | MX$55.26 3.27 USD | ||
| Roche Holding AG RHO6.F | €41.90 45.8 USD |
-0.57
|
€266.93B 291.79B USD | €380.00 415.39 USD | €41.17 45 USD | €41.91 45.81 USD | €266.93B 291.79B USD | 26.51 | €1.58 1.73 USD | ||
| Merck & Co., Inc. MRK.PA | €101.40 110.84 USD |
0
|
€260.61B 284.88B USD | €250.00 273.28 USD | €100.20 109.53 USD | €101.60 111.06 USD | €260.61B 284.88B USD | 21.03 | €4.82 5.27 USD | ||
| AstraZeneca PLC AZNCF | $182.58 — |
+2.66
|
$283.75B — | $300.00 — | $182.58 — | $182.58 — | $283.75B — | 30.37 | $6.01 — | ||
|
좋아하는 주식 없음
아직 즐겨찾는 주식이 없습니다. 여기에서 보려면 즐겨찾기에 추가하세요. |
|||||||||||
- {{ link.label }} {{link}}